Status:
UNKNOWN
Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia
Lead Sponsor:
Asan Medical Center
Conditions:
Dyspepsia
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The aims of the investigators' study are to investigate the effect of H.pylori eradication on the human gut microbiome and symptoms of functional dyspepsia.
Detailed Description
Accumulating evidence shows that Helicobacter pylori protects against some metabolic and immunological diseases in which the development of these diseases coincide with temporal or permanent dysbiosis...
Eligibility Criteria
Inclusion
- Patients who has diagnosed with functional dyspesia by Rome IV criteria
Exclusion
- Known GI malignancy
- Previous Helicobater pylori eradication history
- Severe systemic disease
- Previous GI surgery
- Uncorrectable coagulopathy: INR \> 1.5 or platelet \< 50,000/ml
- Pregnant or breastfeeding women
- Atrophic gastritis, open type
Key Trial Info
Start Date :
June 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04449185
Start Date
June 30 2020
End Date
October 30 2021
Last Update
June 26 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.